Cargando…
MiR-509-5p improves the proliferative and invasive abilities of papillary thyroid carcinoma cells by inhibiting SFRP1
INTRODUCTION: Our study was conducted to prove that miR-509-5p improved the proliferative and invasive abilities of papillary thyroid carcinoma (PTC) cells through inhibiting SFRP1 expression. MATERIAL AND METHODS: QRT-PCR was conducted in order to detect the miR-509-5p expression levels in PTC and...
Autores principales: | Yang, Chunxiao, Wang, Yingluan, Yang, Wenyi, Gao, Yujun, Zhao, Bo, Yang, Xingwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657240/ https://www.ncbi.nlm.nih.gov/pubmed/31360191 http://dx.doi.org/10.5114/aoms.2019.85904 |
Ejemplares similares
-
MiR-345-5p inhibits tumorigenesis of papillary thyroid carcinoma by targeting SETD7
por: Zhao, Ming, et al.
Publicado: (2019) -
MicroRNA-509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma
por: Zhang, Shuilong, et al.
Publicado: (2022) -
MON-532 Characterization of the Angiogenic Factor SFRP2 in Papillary Thyroid Carcinoma
por: Wofford, Wyatt O, et al.
Publicado: (2020) -
miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2
por: Guo, Jiekun, et al.
Publicado: (2019) -
Retracted: miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2
por: Research International, BioMed
Publicado: (2021)